Dabrafenib + Trametinib for cancer treatmentz
Dear Grampian Health Board,
Please answer these questions relating to the usage of Dabrafenib + Trametinib in cancer treatment.
A) Over the previous 6 months, how many patients for the following diseases have been treated with a combination of Dabrafenib + Trametinib:
i) Metastatic Melanoma
ii) Adjuvant Melanoma
iii) BRAF mutated Lung Cancer
I sincerely thank you for taking the time to answer these questions.
Yours faithfully,
David Elder
Dear David Elder,
Freedom of Information (Scotland) Act 2002
Thank you for your email dated 29 June 2022, requesting information
regarding specific drug treatment in cancer care. We have recorded this
request and are currently processing it in accordance with the Freedom of
Information (Scotland) Act 2002.
A response to your request for information is due by 28 July 2022. Please
allow for delivery time.
We will contact you again in due course.
Best wishes,
Susie
Susie Nattrass
Information Governance Officer
Information Governance Team
NHS Grampian
Rosehill House
Cornhill Road
Aberdeen
AB25 2ZG
Phone: 01224 551549
[1][NHS Grampian request email]
--------------------------------------------------------------------------------------------------------------------------------------------------------
This email is intended for the named recipient only. If you have received
it by mistake,
please (i) contact the sender by email reply; (ii) delete the email from
your system; .
and (iii) do not copy the email or disclose its contents to anyone.
--------------------------------------------------------------------------------------------------------------------------------------------------------
References
Visible links
1. mailto:[email address]
Dear Mr Elder
Please find attached response to your request.
Regards
Chris
Chris Morrice
Senior Information Governance Officer
NHS Grampian
Rosehill House
ARI
AB25 2ZG
Email: [email address]
--------------------------------------------------------------------------------------------------------------------------------------------------------
This email is intended for the named recipient only. If you have received
it by mistake,
please (i) contact the sender by email reply; (ii) delete the email from
your system; .
and (iii) do not copy the email or disclose its contents to anyone.
--------------------------------------------------------------------------------------------------------------------------------------------------------
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now